Your browser doesn't support javascript.
loading
Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model.
LeMaistre, Charles F; Wacker, Kara K; Akard, Luke P; Al-Homsi, A Samer; Gastineau, Dennis A; Godder, Kamar; Lill, Michael; Selby, George B; Steinberg, Amir; Anderson, Judy M; Leahigh, Alan K; Warkentin, Phyllis I.
Afiliación
  • LeMaistre CF; Sarah Cannon, Nashville, Tennessee; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: charles.lemaistre@sarahcannon.com.
  • Wacker KK; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska.
  • Akard LP; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Indiana Blood and Marrow Transplantation, Indianapolis, Indiana.
  • Al-Homsi AS; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; NYU Langone Health Blood and Marrow Transplantation Program, New York, New York.
  • Gastineau DA; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; The Blood and Marrow Transplant Program at Mayo Clinic Arizona and Phoenix Children's Hospital, Phoenix, Arizona; Board of Directors, Foundatio
  • Godder K; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Nicklaus Children's Hospital Blood and Marrow Transplant Program, Miami, Florida.
  • Lill M; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Blood and Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California
  • Selby GB; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; The OU Medical Center Blood and Marrow Transplant Program, Oklahoma City, Oklahoma.
  • Steinberg A; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Mount Sinai Bone Marrow and Stem Cell Transplantation Program, New York, New York.
  • Anderson JM; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska.
  • Leahigh AK; Cord Blood Association, Geneva, Illinois.
  • Warkentin PI; Clinical Outcomes Improvement Committee, Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center, Omaha, Nebraska; Board of Directors, Foundat
Biol Blood Marrow Transplant ; 25(11): 2243-2250, 2019 11.
Article en En | MEDLINE | ID: mdl-31284070
The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Foundation for the Accreditation of Cellular Therapy (FACT). These organizations have addressed 2 of the 9 elements identified by the National Quality Strategy (NQS) for achieving better health care, more affordable care, and healthy people and communities: a registry that promotes improvement of care and accreditation based on quality standards. More recently, a federally mandated database in the United States addresses the third element of the NQS: public reporting of treatment results. Here we describe the current process by which FACT incorporates patient outcomes reported by the CIBMTR into standards for accreditation, the requirements for accredited programs with performance below expected outcomes to maintain accreditation, and preliminary findings of an assessment of corrective action plans intended to improve outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Acreditación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Acreditación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article